Who makes Drug Eutirox 100 mcg?

Drug Eutirox 100 mcg is developed by Tecnoquimicas.

What development phase is Drug Eutirox 100 mcg in?

Drug Eutirox 100 mcg is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Drug Eutirox 100 mcg

Tecnoquimicas · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	Drug Eutirox 100 mcg
Sponsor	Tecnoquimicas
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH) (PHASE4)
The Effect of Thyroid Hormone Therapy on Muscle Mass and Function in Older Adults With Subclinical Hypothyroidism (PHASE4)
Bioequivalence Study of Levothyroxine Sodium Tablets 100 mcg (PHASE4)
Effect of Thyroid Hormone Replacement on Fatigability in Untreated Older Adults With Subclinical Hypothyroidism (PHASE4)
Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy (PHASE3)
The TRUST Study - Depression Substudy (PHASE4)
The TRUST Study - CardioVascular Imaging IMT (PHASE4)
The TRUST Trial - CardioVascular Imaging ECHO (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Drug Eutirox 100 mcg CI brief — competitive landscape report
Drug Eutirox 100 mcg updates RSS · CI watch RSS
Tecnoquimicas portfolio CI